ZAYGEO
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ZAYGEO Trademark

Serial Number: 79295699 • Registration: 6465784

ZAYGEO is a trademark filed by LABORATORIOS FARMACEUTICOS ROVI, S.A. on August 26, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

LABORATORIOS FARMACEUTICOS ROVI, S.A.

C/ Julián Camarillo, 35

Entity Type: 85

Trademark Details

Filing Date

August 26, 2020

Registration Date

August 31, 2021

Published for Opposition

June 15, 2021

Goods & Services

Pharmaceutical preparations, namely, antibiotics, analgesics, anaesthetics, amino acids for medical use, antiseptics, tranquilizers, collyriums, digestives for pharmaceutical purposes, laxatives, and prescription synthetic narcotics; Chemical preparations for medical use, being pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of diseases of the central nervous system; tonics being medicines for the treatment of headaches; tranquillizers; soporifics; Pharmaceutical preparations, namely, antipsychotics; medicated serums for the treatment of eczema; hormones; oral contraceptives; vaccines; syringes, vials, cartridges, carpules and ampoules for medical purposes sold filled with pharmaceutical preparations in the nature of antipsychotics; pharmaceutical implants for delivering insulin, namely, implantable subcutaneous drug delivery devices sold filled with insulin; sustained release medicine implants for delivering contraceptives, namely, implantable subcutaneous sustained release drug delivery devices sold filled with contraceptives; oncological preparations being pharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the treatment of diseases of the central nervous system; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for the treatment of damaged skin, thrombosis, coagulation diseases, infections, flu, pain and inflammation; Tranquilizers; prescription synthetic narcotics; antidepressants; anxiolytics being pharmaceutical preparations for the treatment of anxiety; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 25, 2026 NREP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 2, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 2, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 2, 2024 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 11, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 11, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 30, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 31, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 15, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 15, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 26, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 4, 2021 TROA
REFUSAL PROCESSED BY IB
Feb 6, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 19, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 19, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 30, 2020 RFCR
NON-FINAL ACTION WRITTEN
Dec 29, 2020 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 24, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 19, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 15, 2020 REPR